Related Experiment Video
Updated: Apr 22, 2026

06:44
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
Published on: June 7, 2020
7.2K
Brain metastases in breast cancer
Naoki Niikura1, Shigehira Saji2, Yutaka Tokuda3
1Department of Target Therapy Oncology, Kyoto University Graduate School of Medicine, Kyoto Departments of Breast and Endocrine Surgery, Tokai University School of Medicine, Kanagawa niikura@is.icc.u-tokai.ac.jp.
Japanese Journal of Clinical Oncology
|October 17, 2014
Summary
Brain metastases in breast cancer patients have a poor prognosis and are challenging to treat. Advances in detection and therapies offer new hope for managing these challenging brain metastases.
Area of Science:
- Oncology
- Neurology
- Radiology
Background:
- Brain metastases are less common but have a poorer prognosis in breast cancer patients compared to other metastatic sites.
- Neurologic impairments significantly reduce quality of life.
- An increasing incidence of brain metastases is observed, linked to advanced imaging and increased awareness.
Purpose of the Study:
- To provide a comprehensive overview of breast cancer brain metastases.
- To outline current and future management strategies.
- To present a practical treatment algorithm.
Main Methods:
- Review of current literature on incidence, risk factors, diagnosis, and prognosis.
- Analysis of treatment modalities including radiation therapy, surgery, and systemic therapies.
- Evaluation of novel molecular targeted therapies.
Main Results:
- Molecular subtype influences survival outcomes.
- Systemic therapies with poor blood-brain barrier penetration may increase risk.
- HER2-targeted therapy shows promise against brain metastases.
Conclusions:
- Effective management requires a multidisciplinary approach.
- Radiation therapy and surgery are key for local control.
- Emerging targeted therapies offer new treatment avenues for brain metastases.
Related Concept Videos
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Metastasis
3.3K
3.3K

